News
In Novo Nordisk A/S’s home country of Denmark, the popularity of weight-loss drugs is fueling economic growth, but local ...
Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...
Telehealth company Hims & Hers is facing a growing number of U.S. investor lawsuits after Novo Nordisk's decision last month ...
Health plan trustees at a Minneapolis-based construction workers union are suing a subsidiary of UnitedHealth Group for ...
Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...
A new study suggests that drugs like Ozempic and Mounjaro may reduce dementia risk. Researchers at the University of Galway ...
Explore more
The Financial Supervisory Service issued its latest consumer advisory pertaining to insurance claims for various forms of ...
The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the ...
If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...
In an echo of the pattern laid last year, following a record-high outlay at the very beginning of the year, TV drug ad ...
From legal pitfalls to temperature-sensitive drugs, here’s how to travel safely and legally with your medication ...
It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results